Monrovia, CA, United States of America

Jacob Berlin

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Houston, TX (US) (2011 - 2013)
  • Duarte, CA (US) (2017 - 2021)
  • Monrovia, CA (US) (2014 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: Jacob Berlin: Pioneering Innovations in Cancer Treatment

Introduction

Jacob Berlin, an accomplished inventor based in Monrovia, California, has made significant contributions to the field of medical technology, particularly in cancer treatment. With a remarkable portfolio of 16 patents, his innovative work focuses on developing advanced nanoparticle-based therapies, showcasing his commitment to improving patient outcomes.

Latest Patents

Among Jacob Berlin's latest patents is a groundbreaking invention titled "Nanoparticle-cell construct with platinum anti-cancer agent." This patent details compositions that integrate cell-nanoparticle constructs and drug-loaded nanoparticles aimed at cancer treatment. Notably, the technology involves unmodified cisplatin molecules encapsulated by silica nanoparticles, enhancing the therapeutic efficacy against cancer.

Another recent patent, "Compositions and methods of modulating macrophage activity," outlines novel methods to influence macrophage behavior, offering potential treatments for various diseases including macrophage-associated conditions, autoimmune diseases, and cancers located in the intraperitoneal cavity. The patent describes a method of administering a nanoparticle composition intraperitoneally to achieve therapeutic effects, utilizing silica nanoparticles that are non-covalently bound to nucleic acids.

Career Highlights

Jacob Berlin's professional journey includes significant roles at renowned institutions, such as City of Hope and the California Institute of Technology. His work at these organizations has propelled advancements in cancer research and treatment methodologies, amplifying the impact of his innovative patents.

Collaborations

Throughout his career, Jacob has collaborated with esteemed colleagues in the field, including Gregory Copeland and Kathleen Elison. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and further drives the development of cutting-edge solutions in healthcare.

Conclusion

Jacob Berlin stands as a key figure in medical innovation, particularly in the realm of cancer treatment. His extensive patent portfolio and collaborative spirit reflect his dedication to enhancing therapeutic options through inventive approaches. As he continues to push the boundaries of technology, Jacob Berlin is undoubtedly contributing to a brighter future in cancer research and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…